Company facts
- Industry
- Services-Medical Laboratories
- Headquarters
- Austin, Texas
- Most recent report
- 10-Q, filed Aug 7, 2026
- Incorporated
- Delaware
- Filings on record
- 1,000+ filings
- On EDGAR
- CIK 1604821
- Fiscal year ends
- December
- Filer status
- Large accelerated filer
Financials 8 of 18
News 8 of 42
Prospectuses and Registrations 8 of 14
- S-8 Registration statement for an employee plan Aug 7, 2026
- S-8 Registration statement for an employee plan Mar 2, 2026
- S-3ASR Automatic shelf registration Dec 10, 2025
- S-8 Registration statement for an employee plan Dec 5, 2025
- S-3 Shelf registration statement Dec 5, 2025
- S-8 Registration statement for an employee plan Oct 21, 2025
- S-8 Registration statement for an employee plan Feb 28, 2025
- S-8 Registration statement for an employee plan Jul 16, 2024
Proxies 8 of 11
- DEFA14A Extra proxy material Apr 23, 2026
- DEF 14A Proxy statement for a shareholder vote Apr 23, 2026
- DEFA14A Extra proxy material Apr 24, 2025
- DEF 14A Proxy statement for a shareholder vote Apr 24, 2025
- DEFA14A Extra proxy material Jun 5, 2024
- DEFA14A Extra proxy material Apr 24, 2024
- DEF 14A Proxy statement for a shareholder vote Apr 24, 2024
- DEFA14A Extra proxy material Apr 20, 2023
Ownership 8 of 909
- 4 Insider reported a trade Sep 3, 2026
- 4 Insider reported a trade Sep 3, 2026
- 144 Notice of a proposed sale of restricted stock Sep 2, 2026
- 144 Notice of a proposed sale of restricted stock Sep 1, 2026
- 144 Notice of a proposed sale of restricted stock Sep 1, 2026
- 4 Insider reported a trade Aug 28, 2026
- 4 Insider reported a trade Aug 14, 2026
- SCHEDULE 13G/A Large holder reported a passive stake, amended Aug 14, 2026
Other 6
Everything here comes from Natera, Inc.'s own filings on SEC EDGAR. The filing list is rechecked every hour.